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Objective.T oo b s e r v et h ee ﬀect of salvia miltiorrhizae injection on inﬂammatory mediator levels and mesenteric lymph nodes in
severe acute pancreatitis (SAP) and obstructive jaundice (OJ) rats and explore the protective mechanism of salvia miltiorrhizae on
the lymph nodes of these rats. Methods. A total of 288 rats were used in SAP-associated and OJ-associated experiments. The rats
wererandomlydividedintosham-operatedgroup,modelcontrolgroup,andtreatedgroup.Atvarioustimepointsafteroperation,
the pathological changes in mesenteric lymph nodes of rats in each group were observed, respectively. Results. The pathological
severity scores in lymph nodes of SAP rats in treated group were signiﬁcantly lower than those in model control group (P<. 05)
while the pathological changes in lymph nodes of OJ rats in treated group also showed varying degrees of mitigation. Conclusion.
Salvia miltiorrhizae can exert protective eﬀects on the lymph nodes of SAP or OJ rats via a mechanism that is associated with
reducing the contents of inﬂammatory mediators in blood.
Copyright © 2009 Zhang Xiping et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Severe acute pancreatitis (SAP) and obstructive jaundice
(OJ), characterized by multiple complications and high
mortality rate, have become one of the important medical
problems that need to be overcome over the years. The
pathogenesis of two diﬀerent diseases is very complicated. In
recent years, it has been found that the main contributing
factors to the occurrence of multiple organ dysfunction in
SAP and OJ include the massive release of various inﬂam-
matory mediators, the dysregulation of the equilibrium
between proinﬂammatory and antiinﬂammatory eﬀects, and
the disturbance of immune function [1–3].
Therefore, it is important to inhibit the excessive release
of inﬂammatory mediators [4, 5] and restore the function
of the immune system [6] in the therapy of SAP or OJ.
Some clinical studies have shown that salvia miltiorrhizae,
as an auxiliary drug, has some therapeutic eﬀects on SAP
and OJ. Salvia miltiorrhizae is a common Chinese herbal
medicine [7, 8]; it is able to improve the clinical symptoms
in patients with SAP and signiﬁcantly shorten the recovery
duration of urinary amylase and liver function damage,
the remission duration of abdominal pain, as well as the
duration of hospitalization [9, 10].
Moreover, salvia miltiorrhizae can also protect intestinal
mucosa, reduce the translocation of bacteria and endotoxins,
enhancetheimmunity,improveoperativesafety,andshorten
the recovery duration in OJ patients [11]. In our previous
reports,wehavedetectedtheserumcontentsofsomeinﬂam-
matory mediators in SAP and OJ rats (including endotoxin,
PLA2,a n dT N F - α)[ 10, 12–14] and found them signiﬁcantly
increased in model control groups of rats. In this study, we
observed the pathological changes in the mesenteric lymph
nodes of SAP and OJ rats, explored the protective eﬀect
and mechanism of salvia miltiorrhizae injection on lymph
nodes, and further clariﬁed the therapeutic signiﬁcance of
inﬂammatory mediators in SAP and OJ. This study was
closely related to our serial previous reports.
2.MaterialsandMethods
2.1. Materials. 288 healthy male SD rats of clean grade,
weighing between 270 and 330g, were provided by the2 Mediators of Inﬂammation
Laboratory Animal Research Center of the Zhejiang Uni-
versity of Traditional Chinese Medicine (Hangzhou, China);
sodium taurocholate and sodium pentobarbital were pur-
chased from Sigma Corporation Ltd. (St. Louis, MO, USA);
salvia miltiorrhizae injection (each 10mL vial contains active
components equivalent to 15g of the original medicine) was
purchased from Chiatai Qingchunbao Pharmaceutical Co.,
Ltd. (Hangzhou, China).
2.2. Methods
2.2.1. Animal Grouping. 108 rats were used for SAP-
associated experiments and randomly divided into sham-
operated, model controlgroup, and treated group (n = 36),
which were further randomly subdivided into 3-hour, 6-
hour, and 12-hour groups (n = 12) according to time
points after operation; another 180 rats were utilized for OJ-
associated experiments and randomly divided into sham-
operated group, model control group, and treated group
(n = 60), which were further randomly subdivided into 7-
day, 14-day, 21-day, and 28-day groups (n = 15) according
to time duration after operation.
2.2.2. Preparation of SAP Models and Associated Therapeutic
Regimen. The rats were anesthetized with an intraperitoneal
injection of 2.5% sodium pentobarbital (0.2ml/100g).
Under aseptic conditions, the thigh skin was cut open to
expose femoral vein and a transfusion passage was estab-
lished, through which continuous infusion was maintained
using a microinfusion pump (1ml/h/100g). Subsequently,
a median abdominal wall incision was made to expose
duodenal papilla, and a No. 5 syringe needle was used to
prick a small hole in the mesenteric avascular area. The
epidural catheter was ﬁrst inserted into duodenal cavity
via the hole and then placed into the bile-pancreatic duct
towards the direction of papilla. The catheter head was tem-
porarily clamped using a microvascular clamp, and another
microvascular clamp was used to occlude the common bile
duct at the conﬂuence of hepatic ducts to prevent a backﬂow
of injected drugs into the liver. After connecting the epidural
catheter end with the transfusion converter, 3.5% sodium
taurocholate (0.1ml/100g) was transfused at a ﬂow rate
of 0.2ml/min using a microinjection pump (produced by
Zhejiang University, Hangzhou, China). After completing
the transfusion, microvascular forceps and epidural catheter
were maintained for further 4 minutes and then removed.
A checkup was then conducted to see whether bile leakage
was present. After suturing the hole in the lateral wall of the
duodenum, the abdominal cavity was closed conventionally.
Sham-operated group was performed just by moving the
pancreas and duodenum after opening the abdominal cavity.
Fifteen minutes after successful operation, a single dose of
salvia miltiorrhizae injection (0.4ml/100g body weight) was
given via femoral vein to rats in the treated group while
equal volume of physiological saline solution was used in
the sham-operated and the model control groups [10–16].
Continuous infusion of physiological saline solution using a
microinjection pump was then maintained until the end of
the 3-hour, 6-hour, and 12-hour observation periods in the
corresponding groups.
2.2.3. Preparation of OJ Models and Associated Ther-
apeutic Regimen. After rats were anesthetized with an
intraperitoneal injection of 2.5% sodium pentobarbital
(0.2ml/100g), the abdominal cavity was opened to identify
and dissociate common bile duct along the hepatoduodenal
ligament. For rats in the model control group and the
t r e a t e dg r o u p ,t h ep r o x i m a le n do fc o m m o nb i l ed u c tw a s
double-ligated with surgical threads, common bile duct
was cut oﬀ, and a layered suture of the abdominal wall
was performed to close the abdominal cavity. For rats in
the sham-operated groups, common bile duct was only
dissociated but not ligated, and a layered suture of the
abdominal wall was also performed to close the abdominal
cavity. An intraperitoneal injection of salvia miltiorrhizae
injection at a dose of 0.2ml/100g/d was given to rats in
the treated group while equal volume of physiological saline
solution was used in the sham-operated and the model
control groups [10–16]. Injection was maintained until the
end of the 7-day, 14-day, 21-day, and 28-day observation
periods in the corresponding groups.
2.2.4. Specimens Collection. At the corresponding time
points after operation, SAP or OJ rats were anesthetized with
2.5% sodium pentobarbital and mercifully killed. The tissue
specimensofmesentericlymphnodewerecollectedandthen
observed the pathological changes as well as pathological
severity scores, respectively. At 12 hours after operation in
SAP experiment, two rats were randomly selected from each
group, and the ultrastructural changes in the mesenteric
lymph node were observed under an electron microscope.
2.2.5. Statistical Analysis. The compiled data were ﬁrst input
into the Excel sheet and then read into SPSS15.0 for further
analysis. Normal data were expressed as means (standard
deviation) while nonnormal data were expressed as medians
(interquartile range). Analysis of variance and pairwise
comparisons were used for normal data, whereas nonnormal
data were subjected to nonparametric test, among which
Kruskal-Wallis H test was used for pairwise comparisons
and Mann-Whitney U test for multiple comparisons. Yates’
chi-square test (χ2) was used for intergroup comparisons of
mortality rates.
3. Results
3.1. SAP-Associated Experiments
3.1.1. Pathological Changes in Lymph Nodes
(1) Sham-Operated Group. Grossly, the morphology of
lymph nodes was normal. Under light microscopy, the
morphology and structure of lymph nodes were roughly
normal. The expansion of lymph sinuses, the hyperplasia of
sinus cells as well as the ﬁltration of few lymphocytes, and
eosinophilic granulocytes in the sinuses were observed inMediators of Inﬂammation 3
Figure 1: Model control group: 12 hours in SAP rat focal necrosis
of germinal center of lymph node, HE×400.
Figure 2: Model control group: 12 hours in SAP rat expansion of
lymph sinuses, hyperplasia of sinus cells, and obvious inﬁltration of
many inﬂammatory cells, HE×200.
some rats. Under electron microscopy, the morphology and
structure of lymph nodes were roughly normal.
(2) Model Control Group. Grossly, the morphology of
lymph nodes was roughly normal. Under light microscopy,
slight enlargement and congestion of interstitial capillaries
were observed. Under electron microscopy, mitochondrial
swelling, disappearance and vacuolation, as well as lympho-
cyte necrosis and apoptosis were seen; see Figures 1 and 2.
(3) Treated Group. Grossly, the morphology of lymph nodes
was roughly normal. Under light microscopy, the patholog-
ical changes were slightly mitigated when compared with
those in model control group. Under electron microscopy,
the swelling, disappearance, and vacuolation of few mito-
chondria were seen; see Figure 3.
3.1.2. Comparison of the Pathological Severity Scores in Lymph
Nodes. The pathological score of lymph nodes was con-
ducted according to the standard reported in the literature
[17]. At all time points after operation, no signiﬁcant
diﬀerence in the pathological severity scores in lymph nodes
was noted between sham-operated group and model control
group (P>. 05); at 6 hours after operation, the pathological
score in treated group was signiﬁcantly higher than that in
Figure 3: Treated group: 12 hours in SAP rat expansion of lymph
sinuses, hyperplasia of sinus cells, and inﬁltration of small part of
some lymphocytes, HE×200.
Figure 4: Model control group: 28 days in OJ rat hyperplasia of
sinus cells, inﬁltration of a little eosinophile granulocytes, and a
little hemorrhage, HE×200.
sham-operated group (P<. 05); at 3 and 6 hours after
operation, the pathological severity scores in treated group
were signiﬁcantly lower than those in model control group
(P<. 05); see Table 1.
3.2. OJ-Associated Experiments
3.2.1. Pathological Changes in Lymph Nodes
(1) Sham-Operated Group. Grossly, the morphology of
lymph nodes was normal. Under light microscopy, no
marked diﬀerence in pathological changes was observed
among each time points after operation; the morphology
and structure of lymph nodes were roughly normal; the
enlargement of the follicular germinal centers and the
hyperplasia of sinus cells were seen in few rats.
(2) Model Control Group. Grossly, lymph nodes became
yellow in half of the rats on 7 days after operation and in
the majority of rats on 14, 21, and 28 days after operation;
the texture of lymph nodes showed no alterations at all
time points after operation. Under light microscopy, no
marked diﬀerence in pathological changes was observed
among each time points after operation; on 7 days after
operation, the enlargement of the follicular germinal centers4 Mediators of Inﬂammation
Table 1: Comparison of pathological score of lymph node in SAP groups (M(QR)).
Indexes
Sham-operated group Model control group Treated group
3 hours 6 hours 12 hours 3 hours 6 hours 12 hours 3 hours 6 hours 12 hours
Pathological
score
2.00 2.00 2.00 2.00 2.00 2.00 1.00+ 1.00∗∗∗+ 1.00
(1.00) (0.00) (0.50) (1.00) (0.00) (1.00) (2.00) (1.50) (1.00)
Note. Compare to sham-operated group, ∗∗∗P<. 001; compare to model control group, +P<. 05.
Figure 5: Treated group: 28 days in OJ rat expansion of lymph
sinuses, hyperplasia of sinus cells, and inﬁltration of inﬂammatory
cells, HE×200.
and the hyperplasia of sinus cells were seen in the majority
of rats, and few rats showed no obvious pathological changes
in lymph nodes; on 14 days after operation, the enlargement
of the follicular germinal centers and the hyperplasia of
sinus cells were seen; on 21 and 28 days after operation,
the enlargement of the follicular germinal centers and the
hyperplasia of sinus cells were seen in the majority of rats,
and spotty necrosis could be seen in the mantle zone and
germinal centers; see Figure 4.
(3) Treated Group. Grossly, the pathological changes showed
no marked diﬀerence on 7 days after operation when
compared with those in model control group; on 14 days
after operation, lymph nodes became yellow but showed no
marked diﬀerence compared with those in model control
group; on 21 and 28 days after operation, the pathological
changes showed no marked diﬀerence compared with those
in model control group. Under light microscopy, no marked
diﬀerence in pathological changes was observed among each
time points after operation; at all time points afteroperation,
the boundary of the follicular germinal centers in lymph
nodes was clear; the enlargement of the follicular germinal
centers and the hyperplasia of sinus cells were seen in the
majorityofrats;andfewratsshowednoobviouspathological
changes in lymph nodes; see Figure 5.
3.2.2. Comparison of the Pathological Severity Scores in Lymph
Nodes. The pathological score of lymph nodes was con-
ducted according to the standard reported in the literature
[17]. On 14, 21, and 28 days after operation, the pathological
severity scores in lymph nodes in model control group were
signiﬁcantly higher than those in sham-operated group (P<
.05); at all time points after operation, the pathological
severity scores in treated group were signiﬁcantly higher
than those in sham-operated group (P<. 05), and no
signiﬁcant diﬀerence was noted between treated group and
model control group (P>. 05); see Table 2.
4. Discussion
Although the pathogenesis of SAP and OJ is very com-
plicated, their ultimate outcomes are always local and
systemic inﬂammatory response [18]t h a tw i l le v e n t u a l l y
induce MODS (multiple organ dysfunction syndrome) and
MOF (multiple organ failure). Besides being involved in the
infections and inﬂammatory damage secondary to SAP or
OJ, the translocation of intestinal bacteria is also closely
related with the decline in the defense function of mesen-
teric lymph nodes [19–22]. Therefore, it is of important
signiﬁcance to protect mesenteric lymph nodes in the
therapy of SAP and OJ. Salvia miltiorrhizae has advantages
of lower cost, extensive pharmacological eﬀects, and fewer
side eﬀects, and it is able to prevent calcium overload,
scavenge oxygen free radicals, protect against inﬂammation,
and improve microcirculation. Some animal experimental
results have shown [23–25] that salvia miltiorrhizae is able
to signiﬁcantly reduce the excessive levels of bilirubin and
endotoxin, antagonize SAP- or OJ-induced increase in the
intestinal permeability and intestinal bacterial translocation,
eﬀectivelyinhibittheproductionofinﬂammatorymediators,
and thereby protect multiple organs. The results of our
previous study showed that the survival rates of SAP and
OJ rats in treated group were higher than those in model
control group [10–16], suggesting that salvia miltiorrhizae
has some therapeutic eﬀects on SAP or OJ rats. However,
no statistical diﬀerence in the survival rates of rats was
noted between treated group and model control group. We
surmise that this may be because the sample size is too
small.
In this study, we found that, on 14, 21, and 28 days
after operation, the pathological severity scores in the lymph
nodes of OJ rats in model control group were signiﬁcantly
higher than those in sham-operated group (P<. 05),
indicating that OJ can induce pathological injury in the
lymphnodesofrats.Underelectronmicroscopy,thenecrosis
and apoptosis of lymphocytes as well as the swelling of
mitochondrial cristae were observed in the lymph nodes of
SAP rats in model control group, suggesting that SAP can
also induce pathological injury in the lymph nodes of rats.
Since both SAP and OJ can induce lymph node injury, they
may threaten the stability of the body’s immune function.Mediators of Inﬂammation 5
Table 2: Comparison of pathological score of lymph node in OJ groups (M(QR)).
Indexes
Sham-operated group Model control group Treated group
7 days 14 days 21 days 28 days 7 days 14 days 21 days 28 days 7 days 14 days 21 days 28 days
Pathological
score
0.00 0.00 0.00 0.00 1.00 1.00∗ 1.00∗ 1.50∗ 1.00∗ 2.00∗ 1.00∗ 1.00∗
(2.00) (1.00) (1.00) (1.00) (2.00) (1.00) (2.00) (1.00) (1.00) (1.50) (0.00) (1.00)
Note. Compare to sham-operated group, ∗P<. 05.
Thus, it is of important signiﬁcance to protect lymph nodes
with drugs.
Endotoxin, as one of the most important inﬂammatory
mediators that are involved in the pathogenesis of SAP and
OJ, may play important roles in the initiation of SIRS/MOD
and the aggravation of AP [26]. It can directly stimulate the
Kupﬀer cells to release inﬂammatory mediators, including
oxygen free radicals, TNF-α, IL-6, and IL-8, and thereby
aggravate the body’s inﬂammatory response [27, 28]. TNF-
α is the most important factor that mediates the toxic eﬀects
of endotoxin. The excessive release of TNF-α may induce a
variety of pathological injuries. PLA2 is a Ca2+-dependent
enzyme [29] .I nS A Pa n dO J ,P L A 2 is activated and massively
released into the blood. After reaching various organs via the
blood circulation, PLA2 can destroy the lipid membrane of
cells and cause direct cytotoxicity. Some studies showed that,
in SAP complicated with MODS, PLA2 could induce severe
damage and dysfunction of lung, liver, kidney and heart
[30] while its antagonists could improve the pathological
changes in SAP [31]. The results of our previous study
showed that the contents of inﬂammatory mediators such
as endotoxin, TNF-α and PLA2 in model control group
were signiﬁcantly higher than those in sham-operated group
[10, 12–14], suggesting that inﬂammatory mediators were
massively released in SAP and OJ. Those results indicated
that salvia miltiorrhizae was able to signiﬁcantly reduce
the levels of endotoxin, TNF-α and PLA2 in SAP and OJ
rats. This may be because salvia miltiorrhizae can eﬀectively
inhibit the release of endotoxin and thereby reduce the
production of other inﬂammatory mediators such as TNF-
α, IL-6, and IL-8. Concomitant with the decline in the
levels of inﬂammatory mediators, at 3 and 6 hours after
operation, the pathological scores in the lymph nodes of
SAP rats in treated group were signiﬁcantly lower than
those in model control group (P<. 05). Under light
microscopy, we found that the boundary of the follicular
germinal centers in lymph nodes of OJ rats in treated group
was clear, and few lymph nodes revealed no abnormality.
Compared to model control group, the pathological changes
in treated group were improved. Therefore, we believe
that inﬂammatory mediator levels are correlated with the
severity of pathological changes in lymph nodes in SAP
and OJ rats. In other words, inﬂammatory mediators can
induce pathological damage in the lymph nodes of rats,
whereas salvia miltiorrhizae can exert protective eﬀects on
the lymph nodes of rats through reducing the levels of
inﬂammatory mediators. Some studies have proved that
salviamiltiorrhizaecanantagonizeendotoxin-inducedeﬀects
[32]. We think that salvia miltiorrhizae exerts its protective
eﬀect on lymph nodes mainly through the following two
aspects.
Antiinﬂammatory Eﬀect. The inﬂammatory mediators pro-
duced in SAP and OJ can cause intestinal mucosal dam-
age. Both endotoxin and TNF-α can directly induce local
ischemia and increased permeability of intestinal mucosa,
mediate the massive production of cytokines and pro-
inﬂammatory response, and thereby induce the necrosis and
apoptosis of cells as well as multiple organ dysfunction
[33–37]. Through inhibiting the production of endotoxin
and blocking the pathways through which inﬂammatory
cytokines are produced, salvia miltiorrhizae is able to eﬀec-
tively modulate the gut microenvironment, protect mesen-
teric lymph nodes, and restore intestinal barrier function.
Our series of studies, which have been or will be reported in
other papers, have proved that salvia miltiorrhizae is able to
protect intestinal mucosa, providing a further basis for this
hypothesis.
Improving the Body’s Immune Function. It has been pointed
o u ti ns o m es t u d i e s[ 38] that endotoxin can aﬀect the
body’s immune function through inducing the production
of inﬂammatory mediators. The decline in immune func-
tion can impair the body’s antiinfection ability, increase
the translocation of intestinal bacteria and endotoxins,
and aggravate inﬂammatory response and tissue damage.
Therefore, suppressing the production of inﬂammatory
mediators, such as endotoxin, TNF-α,a n dP L A 2,c a nb l o c k
inﬂammatory mediator-induced damage to the immune
defense system, which is important for stabilizing the body’s
immune system. Since salvia miltiorrhizae perhaps has this
eﬀect, it is worthy to deeply study its eﬀect on the immune
function in the future.
In short, salvia miltiorrhizae is able to protect the mesen-
teric lymph nodes of SAP and OJ rats through reducing
the levels of inﬂammatory mediators in blood. This eﬀect
plays a positive role in stabilizing the body’s immune func-
tion, protecting intestinal mucosa barrier, and reducing the
translocation of bacteria. As the pharmacological eﬀects of
salvia miltiorrhizae are further clariﬁed, salvia miltiorrhizae
will be more widely used to treat SAP and OJ.
Note. We claimed that this paper was original and would not
have any ﬁnancial interest in a company or its competitor
and that all authors meet standard for authorship. We abided
by the ethics in this animal experiment study. The ethics
committee approval of our hospital was secured for the6 Mediators of Inﬂammation
animal study reported, and all rats have not been abused and
executive merciful killing when the observing time in this
study was over was conducted.
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